2022-08-22| FundingSpecial

NIH Provides $23 Million to Fund Telehealth Cancer Care Research

by Reed Slater
Share To
Telehealth is a new form of remote healthcare that uses modern communication technologies like phone, video chat, email, and text message to assist patient care. While rudimentary forms have existed since the advent of the telephone, within the last 10 to 15 years, the field has evolved rapidly to leverage electronic healthcare’s potential for communities worldwide. In an effort to establish a more robust framework for digital healthcare in the cancer care space, the National Cancer Institute, part of the National Institutes of Health, is laying down $23 million to four organizations to fund research efforts. The funding aims better to understand telehealth operations in an ever-increasingly digital landscape to provide broader healthcare access to those who may have a harder time getting face-to-face treatment.

GO Prime with only $1.49 now

Pharming announces US FDA approval of Joenja® (leniolisib) as the first and only treatment indicated for APDS
Moderna Injects $76 Million To Kickstart Lipid Nanoparticle Delivery Partnership With Generation Bio
Shining a Light on Oncology with Rakuten Medical Co-CEO Takashi Toraishi
Incyte’s Zynyz Secures FDA Approval for Treating a Rare and Aggressive Skin Cancer
Biohaven Licenses TYK2/JAK1 Dual Inhibitor From China’s Highlight In $970 Million Pact
FDA Extends Approval Of Regeneron’s Evkeeza For Inherited High Cholesterol
Launching an Innovative Product, PlaClin-M, for Safe Environments in the Pandemic Era.
Scroll to Top